FDA Approves Differin Gel, 0.3% for Acne

2007-06-20 | 03:04

FDA Approves Differin Gel, 0.3% for Acne

Galderma Laboratories, L.P., announced that the Food and Drug Administration has approved Differin Gel, 0.3%, a new, higher concentration formulation of the topical retinoid indicated for the treatment of acne. The more potent formulation is efficacious enough to treat  moderate to moderately-severe acne. Differin Gel, 0.3% will be available by prescription by July 2007.